PATENT CLAIM ANALYSIS

Application Number: 16204074
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "171000"]

Abstract:
Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.

Claim (Index 2):
The method of  claim 1  wherein the patient is administered ganaxolone twice daily.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15191068', '15961002', '14876110', '15493374', '15904901']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7787597023274585
- 35 USC 102 Novelty (BERT): 0.5368107905205171
- Combined Prediction Score: 0.7545648111467643
- Mean Citation Score: 295.16178
- Max Citation Score: 360.07504
- Similarity Product: 205.0207872603416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test